Contrasting Heyu Biological Technology (OTCMKTS:HYBT) and Tivic Health Systems (NASDAQ:TIVC)

Heyu Biological Technology (OTCMKTS:HYBTGet Free Report) and Tivic Health Systems (NASDAQ:TIVCGet Free Report) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends.

Insider & Institutional Ownership

9.6% of Tivic Health Systems shares are owned by institutional investors. 89.2% of Heyu Biological Technology shares are owned by insiders. Comparatively, 2.7% of Tivic Health Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Volatility & Risk

Heyu Biological Technology has a beta of -17.74, indicating that its share price is 1,874% less volatile than the S&P 500. Comparatively, Tivic Health Systems has a beta of 2.79, indicating that its share price is 179% more volatile than the S&P 500.

Earnings & Valuation

This table compares Heyu Biological Technology and Tivic Health Systems’ revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Heyu Biological Technology $80,000.00 348.59 -$270,000.00 N/A N/A
Tivic Health Systems $1.84 million 1.04 -$10.10 million ($42.48) -0.03

Heyu Biological Technology has higher earnings, but lower revenue than Tivic Health Systems.

Profitability

This table compares Heyu Biological Technology and Tivic Health Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Heyu Biological Technology -453.55% -6.43% -4.43%
Tivic Health Systems -672.78% -185.91% -134.45%

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Heyu Biological Technology and Tivic Health Systems, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Heyu Biological Technology 0 0 0 0 N/A
Tivic Health Systems 0 0 0 0 N/A

Summary

Heyu Biological Technology beats Tivic Health Systems on 6 of the 9 factors compared between the two stocks.

About Heyu Biological Technology

(Get Free Report)

Hong Chang Biotechnologies (HK) Limited was incorporated in 2023 and is based in Kowloon, Hong Kong. Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Zengqiang Investment Limited. As of September 4, 2023, Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Heyu Biological Technology Corporation.

About Tivic Health Systems

(Get Free Report)

Tivic Health Systems Inc. operates as a health technology company, focuses on developing and commercializing non-invasive bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal congestion pains. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Receive News & Ratings for Heyu Biological Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heyu Biological Technology and related companies with MarketBeat.com's FREE daily email newsletter.